Baby Powder Mesothelioma Lawsuit Trial Ends in $45M Verdict Against Johnson & Johnson
An Illinois jury determined that asbestos in Johnson's Baby Powder caused a woman's death from mesothelioma, awarding her family $45 million in damages.
An Illinois jury determined that asbestos in Johnson's Baby Powder caused a woman's death from mesothelioma, awarding her family $45 million in damages.
The verdict marks the first talcum powder ovarian cancer lawsuit to be completed since Johnson & Johnson attempted to force the settlement of all claims through the U.S. Bankruptcy system, delaying the litigation for two years.
The draft findings come shortly after a ban was announced last month on the last forms of asbestos that were still legally allowed to be used in the United States.
In response to continuing concerns about the health risks linked to asbestos in talc-based products, the FDA plans to implement new regulations that will establishing testing standards.
This new delay may lead to more women dying before their talcum powder lawsuits get the opportunity to go before a jury, plaintiffs' attorneys warn.
The rule includes new workplace safety requirements for those industries given more than two years to phase out chrysotile asbestos.
Lawsuit claims numerous talcum powder products used during a Massachusetts woman's life exposed her to asbestos, resulting in a mesothelioma diagnosis in March 2023
Asbestos risks in older federal buildings makes it difficult to sell them and recoup taxpayer money spent on cleanup and maintenance, officials say.
Jury was deadlocked in the first trial over the talcum powder ovarian cancer side effects to be held since a stay was lifted when Johnson & Johnson's bankruptcy bids were rejected by the federal court system.
Mesothelioma cancer patients given pegargiminase had a 29% lower risk of death and 35% lower risk of disease progression in a recent clinical study.